INS and type 1 diabetes mellitus: For example, prolonged fasting was tested in a pilot study including 20 patients with type 1 diabetes and the study demonstrated no ketoacidosis, insulin reduction (24.4 to 7.6 IU), and sustained BMI decrease at 4 months, with quality of life normalization, supporting adaptive benefits under supervision even in high risk phenotypes [176].